Skip to main content

Advertisement

SpringerLink
Log in

The alpha-herpesviridae in dermatology

Varicella zoster virus

Alpha-Herpesviridae in der Dermatologie

Varicella-Zoster-Virus

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Abstract

The second part of this publication deals with varicella zoster virus (VZV) and presents an overview of new, rare, and atypical clinical manifestations, including photolocalized varicella, hemorrhagic bullae during varicella, the implication of VZV in immunoglobulin A vasculitis, VZV-related alopecia, ulcerative varicella skin lesions, childhood herpes zoster (HZ), prolonged prodromal pains, recurrent HZ, VZV implication in burning mouth syndrome, verruciform VZV lesions, the significance of satellite lesions during HZ, and late HZ complications, either neurological or internal. Furthermore, certain associations between the occurrence of HZ and subsequent internal pathologies, as well as risk factors for HZ and new developments in vaccination against HZ will be addressed.

Zusammenfassung

Der zweite Teil der vorliegenden Übersichtsarbeit befasst sich mit dem Varicella-Zoster-Virus (VZV) und bietet einen Überblick über neue, seltene und atypische klinische Symptome: fotolokalisierte Varizellen (an lichtexponierten Stellen), hämorrhagische Bullae während der Varizelleninfektion, Bedeutung des VZV bei Immunglobulin-A-Vaskulitis, VZV-bedingte Alopezie, ulzerative Varizellen-Hautläsionen, kindlicher Herpes zoster (HZ), anhaltende Prodromalschmerzen, rezidivierender HZ, Bedeutung des VZV beim Burning-Mouth-Syndrom, warzenähnliche VZV-Läsionen, Bedeutung von Satellitenläsionen bei HZ und neurologische oder internistische Spätkomplikationen des HZ. Darüber hinaus werden bestimmte Zusammenhänge zwischen dem Auftreten des HZ und nachfolgenden internistischen Erkrankungen, Risikofaktoren für HZ und neue Entwicklungen bei der Impfung gegen HZ dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Calabrese LH, Xie F, Yun H, Winthrop K, Baddley JW, Calabrese C, Curtis JR (2016) Herpes zoster and the risk for stroke in patients with autoimmune diseases. Arthritis Rheumatol. doi:10.1002/art.39855

    Google Scholar 

  2. Canelas C, Carvas JM, Sevivas C, Carvalho D (2016) Image diagnosis: hemorrhagic bullae in a primary varicella zoster virus infection. Perm J 20. doi:10.7812/TPP/15-206

    PubMed  PubMed Central  Google Scholar 

  3. Chen YT, Wang HH, Wang TJ, Li YC, Chen TJ (2016) Early application of low-level laser may reduce the incidence of postherpetic neuralgia (PHN). J Am Acad Dermatol 75:572–577

    Article  PubMed  Google Scholar 

  4. Clark CM, Huntley C, Carr MM (2016) Varicella infection complicated by group A beta-hemolytic streptococcal retropharyngeal abscess. Case Rep Otolaryngol. doi:10.1155/2016/9298143

    PubMed  PubMed Central  Google Scholar 

  5. Cotton SJ, Belcher J, Rose P, Jagadeesan SK, Neal RD (2013) The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study. Br J Cancer 108(3):721–726. doi:10.1038/bjc.2013.13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Díez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barberà J, Vanden Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC, ZOE-70 Study Group (2016) Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375:1019–1032

    Article  CAS  PubMed  Google Scholar 

  7. El Hayderi L, Nikkels-Tassoudji N, Nikkels AF (2013) Hair loss after varicella zoster virus infection. Case Rep Dermatol 5:43–47. doi:10.1159/000348648

    Article  PubMed  PubMed Central  Google Scholar 

  8. El Hayderi L, Bontems S, Nikkels-Tassoudji N, Arrese JE, Seidel L, Meex C, Nikkels AF (2015) Satellite lesions accompanying herpes zoster: a new prognostic sign for high-risk zoster. Br J Dermatol 172:1530–1534

    Article  PubMed  Google Scholar 

  9. El Hayderi L, Rübben A, Nikkels AF (2016) The alpha-herpesviridae in dermatology. Herpes simplex virus types I and II. Hautarzt. 10.1007/s00105-016-3919-7

    Google Scholar 

  10. El Hayderi L, Colson F, Dezfoulian B, Nikkels AF (2016) Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact and management challenges. Psoriasis Target Ther 6:145–151

    Article  Google Scholar 

  11. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K (2015) Varicella zoster virus infection. Nat Rev Dis Primers 1:15016. doi:10.1038/nrdp.2015.16

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC, ZOE-50 Study Group (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372(22):2087–2096

  13. Lin TY, Yang FC, Lin CL, Kao CH, Lo HY, Yang TY (2016) Herpes zoster infection increases the risk of peripheral arterial disease: a nationwide cohort study. Medicine (Baltimore) 95:e4480

    Article  Google Scholar 

  14. Mallick-Searle T, Snodgrass B, Brant JM (2016) Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc 9:447–454

    Article  PubMed  PubMed Central  Google Scholar 

  15. Matthews A, Turkson M, Forbes H, Langan SM, Smeeth L, Bhaskaran K (2016) Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the UK Clinical Research Practice Datalink. Br J Dermatol. doi:10.1111/bjd.14815

    PubMed  PubMed Central  Google Scholar 

  16. Mullane KM, Nuss C, Ridgeway J, Prichard MN, Hartline CB, Theusch J, Mommeja-Marin H, Larson RA (2016) Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host. Transpl Infect Dis 18:785–790

    Article  CAS  PubMed  Google Scholar 

  17. Nagel MA, Gilden D (2016) Burning mouth syndrome associated with varicella zoster virus. BMJ Case Rep. doi:10.1136/bcr-2016-215953

    PubMed  PubMed Central  Google Scholar 

  18. Nikkels AF, Nikkels-Tassoudji N, Piérard GE (2004) Revisiting childhood herpes zoster. Pediatr Dermatol 21:18–23

    Article  PubMed  Google Scholar 

  19. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL, Shingles Prevention Study Group (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271–2284

    Article  CAS  PubMed  Google Scholar 

  20. Peng YH, Fang HY, Wu BR, Kao CH, Chen HJ, Hsia TC, Liao WC (2016) Adult asthma is associated with an increased risk of herpes zoster: a population-based cohort study. J Asthma 13:1–8

    Google Scholar 

  21. Peterson N, Goodman S, Peterson M, Peterson W (2016) Herpes zoster in children. Cutis 98:94–95

    PubMed  Google Scholar 

  22. Tasani M, Daniels J, Mellerio J, Martinez A (2016) Ulcerative skin lesions following varicella infection. Arch Dis Child. doi:10.1136/archdischild-2016-311166

    PubMed  Google Scholar 

  23. Ushigome Y, Yamazaki Y, Shiohara T (2016) IgA vasculitis with severe gastrointestinal symptoms may be an unusual manifestation of varicella-zoster virus reactivation. Br J Dermatol. doi:10.1111/bjd.14948

    PubMed  Google Scholar 

  24. Vázquez-Osorio I, Pérez-Martín JA, Rodríguez-Díaz E (2016) Photolocalized or actinic chickenpox. Med Clin (Barc). doi:10.1016/j.medcli.2016.07.003

    Google Scholar 

  25. Wang L, Zhu L, Zhu H (2016) Efficacy of varicella (VZV) vaccination: an update for the clinician. Ther Adv Vaccines 4:20–31. doi:10.1177/2051013616655980

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wang YP, Liu CJ, Hu YW, Chen TJ, Lin YT, Fung CP (2012) Risk of cancer among patients with herpes zoster infection: a population-based study. CMAJ 184:E804–E809

    Article  PubMed  PubMed Central  Google Scholar 

  27. Wang WY, Liu SH, Lin MY, Lin CC, Wang IJ (2016) Initial presentation sites as predictors of herpes zoster complications: a nationwide cohort study. PLOS ONE 6(11):e0164019

    Article  Google Scholar 

  28. Wauters O, Lebas E, Nikkels AF (2012) Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections. J Am Acad Dermatol 66:e217–e227

    Article  PubMed  Google Scholar 

  29. Werner RN, Nikkels AF, Marinovi B, Schäfer M, Czarnecka-Opera M, Agius AM, Bata-Csörgő Z, Breuer J, Girolomoni G, Gross GE, Langan S, Lapid-Gortzak R, Lesser TH, Pleyer U, Sellner J, Verjans GM, Wutzler P, Dressler C, Erdmann R, Rosumeck S, Nast A (2016) European consensus-based (S2k) guideline on the management of herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 1: diagnostic means. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.13995

    Google Scholar 

  30. Werner RN, Nikkels AF, Marinović B, Schäfer M, Czarnecka-Operacz M, Agius AM, Bata-Csörgő Z, Breuer J, Girolomoni G, Gross GE, Langan S, Lapid-Gortzak R, Lesser TH, Pleyer U, Sellner J, Verjans GM, Wutzler P, Dressler C, Erdmann R, Rosumeck S, Nast A (2016) European consensus-based (S2k) guideline on the management of herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 2: treatment. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.13957

    Google Scholar 

  31. Wurzer P, Guillory A, Parvizi D, Clayton RP, Branski LK, Kamolz LP, Finnerty CC, Herndon DN, Lee JO (2016) Human herpes viruses in burn patients: a systematic review. Burns. doi:10.1016/j.burns.2016.02.003

    Google Scholar 

  32. Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P (2011) Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 86:88–93

    Article  PubMed  PubMed Central  Google Scholar 

  33. Yawn BP, Wollan PC, Nagel MA, Gilden D (2016) Risk of stroke and myocardial infarction after herpes zoster in older adults in a US community population. Mayo Clin Proc 91:33–44. doi:10.1016/j.mayocp.2015.09.015

    Article  PubMed  Google Scholar 

  34. Zerngast WW, Paauw DS, O’Connor KM (2013) Varicella zoster with extended prodrome: a case series. Am J Med 126:359–361. doi:10.1016/j.amjmed.2012.09.009

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, CHU of Sart Tilman, University of Liège, 4000, Liège, Belgium

    L. El Hayderi MD, PhD &  A. F. Nikkels MD, PhD

  2. Department of Dermatology, RWTH Aachen, Aachen, Germany

    A. Rübben MD, PhD

Authors
  1. L. El Hayderi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Rübben MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. F. Nikkels MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. F. Nikkels MD, PhD.

Ethics declarations

Conflict of interest

L. El Hayderi, A. Rübben, and A.F. Nikkels declare that they have no competing interests.

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

The German version of this article can be found under doi:10.1007/s00105-016-3930-z.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El Hayderi, L., Rübben, A. & Nikkels, A.F. The alpha-herpesviridae in dermatology. Hautarzt 68 (Suppl 1), 6–10 (2017). https://doi.org/10.1007/s00105-016-3920-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-016-3920-1

Keywords

Schlüsselwörter

Search

Navigation